NTRK2 and nervous system disorder: Small-molecule compounds specifically acting on TrkB (Jang et al., 2010; Massa et al., 2010) show efficacy in several animal models of neurological diseases (Simmons et al., 2013; Chen et al., 2018; Ren et al., 2019).